SQI Diagnostics (CVE:SQD) will release its earnings data before the market opens on Thursday, May 16th.
SQI Diagnostics (CVE:SQD) last issued its quarterly earnings results on Thursday, February 28th. The company reported C($0.01) earnings per share (EPS) for the quarter. The company had revenue of C$0.29 million during the quarter.
Shares of SQD stock opened at C$0.15 on Tuesday. The stock has a market capitalization of $27.99 million and a P/E ratio of -2.88. SQI Diagnostics has a 52-week low of C$0.05 and a 52-week high of C$0.21. The company has a debt-to-equity ratio of 1,059.03, a quick ratio of 1.82 and a current ratio of 2.31.
SQI Diagnostics Inc, a life sciences company, develops and commercializes proprietary technologies and products for advanced multiplexing diagnostics in Canada. The company offers sqidworks diagnostic platform, a fully-automated microarray processing and analytical system; sqidlite benchtop diagnostic platform, a fully automated bench top microarray processing and analytical system; and sqid-X, a semi-automated bench-top platform.
Read More: Trading Ex-Dividend
Receive News & Ratings for SQI Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SQI Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.